SIPOGLITAZAR
UNII 40O898CJZB

Substance Identification & Data

This profile provides standardized clinical and technical data for Sipoglitazar, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 40O898CJZB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 342026-92-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

40O898CJZB

CAS Registry Number

342026-92-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SIPOGLITAZAR

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C25H25N3O4S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

SRFCAWATPLCLMG-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C87622

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

9825652

Unique identification number in the NCBI database of chemical substances.

INN ID

8610

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1cc(ccc1Cn2nc(OCC)c(c2)CCC(O)=O)OCc3nc(sc3)-c4ccccc4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sipoglitazar. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.